A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

​ Conditions: Colorectal Cancer Interventions: Drug: Telisotuzumab Adizutecan; Drug: Standard of Care Sponsors: AbbVie Not yet recruiting Conditions: Colorectal Cancer Interventions: Drug: Telisotuzumab Adizutecan; Drug: Standard of Care Sponsors: AbbVie Not yet...

Sepsis and Hospital Mortality

​ Conditions: Sepsis Interventions: Diagnostic Test: conductivity and dieletric constant Sponsors: University of Calabria Not yet recruiting Conditions: Sepsis Interventions: Diagnostic Test: conductivity and dieletric constant Sponsors: University of Calabria Not yet...